Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In the quest to conquer cancer, data is our most powerful ally. Yet, data, when stripped of its human context, can feel cold and abstract. We speak of Kaplan-Meier curves, hazard ratios, and statistical significance, but behind these numbers lie…
In the digital age of algorithms and artificial intelligence, there remains a domain where the human eye, trained to a degree of almost preternatural perception, is the ultimate arbiter of truth. This is the world of surgical pathology, and its…
In the vast and often bewildering landscape of cancer research, the individual tumor has long been studied as a solitary mountain—unique, formidable, and requiring a full expedition to understand. While this approach has yielded invaluable insights, it has also been…
Rare cancers, by definition, present a formidable challenge: the scarcity of high-quality, clinically annotated tissue samples. This scarcity severely hinders biomarker discovery, therapeutic target validation, and the development of diagnostic tools, leaving patients with limited options. Traditional Tissue Microarrays (TMAs),…
Tissue Microarrays (TMAs) revolutionized immunohistochemistry (IHC) by enabling the simultaneous analysis of tens to hundreds of tissue cores on a single slide. Their primary recognized value lies in high-throughput screening: rapidly validating biomarkers across large cohorts, assessing inter-observer variability, or…
FFPE (Formalin-Fixed Paraffin-Embedded) tissue samples are the bedrock of clinical trial validation in oncology and beyond. They provide the crucial link between a drug’s mechanism of action observed in vitro or in animal models and its actual effect within the complex human…
In the intricate world of diagnostic pathology, where accuracy directly impacts patient lives, the paraffin tissue block stands as the unshakeable bedrock of quality control (QC). This seemingly simple wax-embedded archive of patient tissue is far more than a storage…
In the relentless pursuit of novel therapeutics, the ability to rapidly and efficiently screen drug candidates against biologically relevant targets is paramount. Tissue Microarrays (TMAs) have revolutionized this landscape, emerging as powerful high-throughput engines that dramatically accelerate and refine the…
In the wave of translational medicine, the search for reliable, reproducible biomarkers serves as the critical bridge connecting basic research with clinical application. Formalin-Fixed Paraffin-Embedded (FFPE) tissue blocks, the most ubiquitous and invaluable resource in global biobanks, are emerging as…
Introduction The success of precision oncology depends heavily on identifying and validating reliable biomarkers. From predicting drug response to monitoring resistance, biomarkers shape treatment strategies and guide clinical decision-making. However, robust biomarker discovery requires access to high-quality, reproducible specimens. This…
